Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the radiation therapy oncology group 0129 trial: Long-term report of efficacy and toxicity - Nguyen-Tan, P F; Zhang, Q; Ang, K K (Journal of Clinical Oncology, 2014)
. doi:10.1200/JCO.2014.55.3925